N/A
Completed N=12
Efficacy Study Regarding the Beneficial Effects of Omega-3 Fatty Acids on Cardiometabolic Health
Metabolic Syndrome X
Source: ClinicalTrials.gov NCT02042274 ↗
Enrolled (actual)
12
Serious AEs
0.0%
Results posted
Apr 2017
Primary outcomePrimary: Blood Triglyceride — 0.9; 0.8; 0.9 mmol/L
Summary
Fish oil supplements (which are rich in omega-3 fatty acids) have been shown to provide cardiometabolic benefits to individuals of all ages. Specifically, the daily consumption of fish oil supplements has been reported to reduce blood triglyceride levels, and influence glucose homeostasis and whole-body inflammation. However, recent evidence highlights important gaps in our understanding with respect to the impact of fish oil supplements on health; specifically, not everyone responds to these supplements in the same manner. The goal of this research is to explore how an individual's genetic make-up may modify their response to fish oil supplements.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Blood Triglyceride |
0.9; 0.8; 0.9 | — |
| SECONDARY Blood Glucose |
4.4; 3.9; 4.2 | — |
Eligibility Criteria
Inclusion Criteria
- between 18-25 years old
- male
- good general health
Exclusion Criteria
- currently taking a fish oil supplement
- currently taking an omega-3 supplement
- currently consuming a diet high in omega-3 (high in ALA, EPA, or DHA)
- not able to maintain a consistent lifestyle routine throughout the study duration
- have an allergy which would prevent them from taking a fish oil pill
- schedule conflict with study visits
- overweight or obese
Data sourced from ClinicalTrials.gov (NCT02042274). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.